New York Times on amyloid screening

18 Nov

Amyloid plaques are found in the brains of individuals with Alzheimer’s disease. It is unclear if they are a cause of a consequence of the disorder. Yesterday’s New York Times carried this piece about the controversy surrounding a new screening procedure for amyloid. 

The article includes this grim overview of the Alzheimer’s crisis:

“The personal effects are devastating, but so are the societal ones. In 1980, nearly three million Americans had dementia caused by Alzheimer’s. That number has since doubled. Some estimates show that, in the next 40 years, it will increase almost threefold, to 16 million. This is because the greatest risk factor for developing Alzheimer’s dementia is old age, and America is rapidly aging. One in nine Americans over 65 have the disease, and one in three over 85. This adds up to $200 billion a year in health care costs, not counting the tens of billions in unpaid care that families provide.”

One Response to “New York Times on amyloid screening”

  1. moore314 November 18, 2013 at 2:15 pm #

    Thank you for pointing to the article.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: